Correction (DOI:10.1016/j.ahj.2009.06.009);Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction

American Heart Journal

Volumn 158, Issue 3, 2009, Pages 356-363

  Traverse, Jay H ^a,b   Henry, Timothy D ^a,b   Vaughn, Douglas E ^c   Ellis, Stephen G ^d   Pepine, Carl J ^e   Willerson, James T ^f   Zhao, David X M ^c   Piller, Linda B ^g   Penn, Marc S ^d   Byrne, Barry J ^e   Perin, Emerson C ^f   Gee, Adrian P ^h   Hatzopoulos, Antonis K ^c   McKenna, David H ^b   Forder, John R ^e   Taylor, Doris A ^b   Cogle, Christopher R ^e   Olson, Rachel E ^a   Jorgenson, Beth C ^c   Sayre, Shelly L ^g   Vojvodic, Rachel W ^g   Gordon, David J ⁱ   Skarlatos, Sonia I ⁱ   Moye', Lemuel A ^f   Simari, Robert D ^j   more..

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f TEXAS HEART INSTITUTE   (United States)

^g UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^h Houston   (United States)

ⁱ NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^j MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PLACEBO;

ACUTE HEART INFARCTION; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CELL THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT;

EID: 68849129353     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.10.016     Document Type: Erratum

References (23)

1. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
2. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
3. Jackson K.A., Majka S.M., Wang H., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107 (2001) 1395-1402
4. Yoon Y.S., Wecker A., Heyd L., et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. JCI 115 (2005) 326-338
5. Murry C.E., Soopa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
6. Balsam L.B., Wagers A.J., Christensen J.L., et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischemic myocardium. Nature 428 (2004) 668-673
7. Schächinger V., Erbs S., Elsässer A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. NEJM 355 (2006) 1210-1221
8. Janssens S., Dubois C., Bogaert J., et al. Autologous bone marrow-derived stem cell transfer in patients with ST-segment elevation myocardial infarction: doubleblind, randomised controlled trial. Lancet 367 (2006) 113-121
9. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet 364 (2004) 141-148
10. Lunde K., Solheim S., Aakhus S., et al. Intracoronary injection of mononuclear bone marrow cells in acute wall infarction. NEJM 355 (2006) 1199-1209
11. Lipinski M.J., Biondi-Zoccai G.G.L., Abbate A., et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction. JACC 50 (2007) 1761-1767
12. Martin-Rendon E., Brunskill S.J., Hyde C.J., et al. Autologous bone marrow stem cells to treat acute myocardial infarction: a systemic review. Eur Heart J 29 (2008) 1807-1818
13. Askari A.T., Unzek S., Popovic Z.B., et al. Effect of stromal-cell-derived factor 1 on stem cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362 (2003) 697-703
14. Nian M., Lee P., Khaper N., and Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94 (2004) 1543-1553
15. Aktas M., Radke T.F., Strauer B.E., et al. Separation of adult bone marrow mononuclear cells using the automated closed separation system Sepax. Cytotherapy 10 (2008) 203-211
16. Traverse J.H., and Henry T.D. Cell therapy for acute myocardial infarction-where do we go from here?. J Cardiovasc Trans Res 1 (2008) 64-70
17. Schachinger V., Aicher A., Dobert N., et al. Pilot trial on determinants of progenitor cell recruitment to the infracted human myocardium. Circulation 118 (2008) 1425-1432
18. Kinnaird T., Stabile E., Burnett M.S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promotes in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94 (2004) 678-685
19. Massa M., Rosti V., Ferrario M., et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105 (2005) 199-206
20. Seeger F.H., Tonn T., Krzossok N., et al. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 28 (2007) 766-772
21. Meluzin J., Mayer J., Groch L., et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of dose of transplanted cells on myocardial function. Am Heart J 152 (2006) 975.e9-975.e15
22. Heeschen C., Lehmann R., Honold J., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109 (2004) 1615-1622
23. Tepper O.M., Galiano R.D., Capla J.M., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion and incorporation into vascular structures. Circulation 106 (2002) 2781-2786